Saudi Central Bank Buys 5,677 Shares of Synopsys, Inc. $SNPS

Saudi Central Bank raised its stake in Synopsys, Inc. (NASDAQ:SNPS) by 80.4% during the 2nd quarter, Holdings Channel.com reports. The firm owned 12,739 shares of the semiconductor company’s stock after buying an additional 5,677 shares during the quarter. Saudi Central Bank’s holdings in Synopsys were worth $5,682,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in SNPS. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Synopsys in the second quarter worth $747,400,000. Norges Bank purchased a new stake in shares of Synopsys during the 4th quarter valued at $730,197,000. Man Group plc acquired a new stake in shares of Synopsys in the 2nd quarter worth $55,900,000. SBI Okasan Asset Management Co.Ltd. acquired a new stake in shares of Synopsys in the 4th quarter worth $1,699,000. Finally, Czech National Bank grew its stake in Synopsys by 4.6% during the 2nd quarter. Czech National Bank now owns 54,526 shares of the semiconductor company’s stock worth $24,322,000 after buying an additional 2,421 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys reported fiscal third-quarter revenue of approximately $2.48 billion and non-GAAP EPS of $3.91, exceeding analyst estimates of $2.44 billion and $3.67, respectively. Revenue grew 42.4% year over year, underscoring continued demand for electronic-design automation and semiconductor IP. Synopsys Results Analysis
• Positive Sentiment: Analysts continue to see significant long-term upside, with reported price targets generally ranging from $450 to $610 and a consensus “Moderate Buy” rating. The bullish case centers on Synopsys’ strategic importance to advanced chip and AI design. Synopsys Wall Street Price Targets
• Neutral Sentiment: Institutional positioning is mixed: 769 investors added SNPS shares in their latest reported quarter, while 764 reduced positions. This suggests continued interest but limited consensus among large investors. Synopsys Institutional Activity
• Negative Sentiment: The earnings beat did not translate into a sufficiently large outlook increase for a stock priced for stronger growth. Full-year guidance implies approximately $9.715 billion of revenue and $15.07 of non-GAAP EPS at the midpoint, prompting a potential “sell-the-news” reaction.
• Negative Sentiment: Investors remain concerned about execution and margin pressure from the Ansys integration. Synopsys reported roughly $236.3 million in restructuring charges during the first nine months of fiscal 2026, while acquired-intangible amortization and approximately $10 billion of debt add to acquisition-related financial risks. Synopsys Ansys Integration Analysis
• Negative Sentiment: Executive Chair Aart de Geus sold 49,641 shares for approximately $21.4 million across August 28, August 31 and September 1. The transactions were made under a pre-arranged Rule 10b5-1 plan, reducing their value as a discretionary bearish signal, but the selling may still weigh on sentiment. Synopsys Insider Selling
• Negative Sentiment: SNPS remains sensitive to higher interest rates and semiconductor-sector weakness. Its valuation remains demanding, with a reported P/E ratio above 69, while the stock is trading below its 200-day moving average. Is Synopsys Stock Underperforming the Nasdaq?

Analysts Set New Price Targets

SNPS has been the topic of several recent analyst reports. Mizuho reduced their target price on Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research report on Thursday, August 27th. Wells Fargo & Company dropped their price target on Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a research report on Thursday, August 27th. Stifel Nicolaus lifted their target price on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, UBS Group set a $570.00 target price on shares of Synopsys in a research report on Thursday, August 27th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and an average target price of $561.28.

Synopsys Price Performance

Synopsys stock opened at $393.84 on Monday. The business’s 50-day simple moving average is $412.27 and its two-hundred day simple moving average is $439.48. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The company has a market cap of $75.48 billion, a PE ratio of 69.58, a PEG ratio of 2.16 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The firm had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same period last year, the business posted $3.39 earnings per share. The company’s revenue for the quarter was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Equities analysts anticipate that Synopsys, Inc. will post 10.97 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Aart de Geus sold 25,000 shares of the firm’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $441.76, for a total transaction of $11,044,000.00. Following the transaction, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,197,180.96. This trade represents a 17.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 92,638 shares of company stock valued at $40,747,732. 0.56% of the stock is owned by insiders.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.